Skip to main content

Advertisement

SpringerLink
Log in

Prostate Artery Embolization: Current Status 2018

  • BPH-Related Voiding Dysfunction (R Lee, Section Editor)
  • Published:
Current Bladder Dysfunction Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Prostate artery embolization (PAE) is a promising new treatment option for men with symptomatic benign prostatic hyperplasia (BPH). Our goal is to review the data on PAE with regard to outcomes, risks versus benefits, and safety.

Recent Findings

Current data suggests that PAE is safe and effective for men with symptomatic BPH. The two most robust randomized controlled trials comparing PAE with TURP both found comparable short-term results with regard to improvements in symptoms. However, the side effects of PAE were higher than those of TURP. There remain ongoing randomized controlled trials comparing the two modalities of treatment.

Summary

Though the largest randomized controlled trials comparing these two modalities of treatment of BPH are still underway, current data suggest PAE may be a promising, safe, and effective treatment option for men with symptomatic BPH. Additionally, PAE can be safely performed on larger prostates of any size and is generally performed via a single, femoral artery puncture under local anesthesia. Therefore, it is particularly appealing for patients with prostate glands > 80 g and who are poor candidates for general anesthesia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. U.S. Food and Drug Administration, Center for Drug Evaluation and Research. Embosphere microspheres DEN160040 approval letter, August 3, 2016. From https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN160040.pdf

  2. McVary KT. BPH: epidemiology and comorbidities. Am J Managed Care. 2006;12(5):S122–8.

    Google Scholar 

  3. Thomas AW, Cannon A, Bartlett E, Ellis-Jones J, Abriams P. The natural history of lower urinary tract dysfunction in men: minimum 10 year urodynamic follow up of transurethral resection of the prostate for bladder outlet obstruction. J Urol. 2005;174:1887–991.

    Article  PubMed  Google Scholar 

  4. Mebust WK, Holtgrewe HL, Cockett AT, Peters PC. Transurethral prostatectomy: immediate and post operative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol. 2002;167:999–1003.

    Article  PubMed  CAS  Google Scholar 

  5. Mitchell ME, Waltman AC, Athanasoulis CA, Ken WS Jr, Dretler SP. Control of massive prostatic bleeding with angiographic techniques. J Urol 1976:115:692–695.

  6. Pereira K, Halpern JA, McClure TD, Lewis NA, Kably I, Bhatia S, et al. Role of prostate artery embolization in the management of refractory haematuria of prostatic origin. BJU Int. 2016;118(3):359–65.

    Article  PubMed  Google Scholar 

  7. DeMerritt JS, Elmasri FF, Esposito MP, Rosenberg GS. Relief of benign prostatic hyperplasia-related bladder outlet obstruction after trans-arterial polyvinyl alcohol prostate embolization. J Vasc Interv Radiol. 2000;11:767–70.

    Article  Google Scholar 

  8. Michel F, Dubruille T, Cercueil JP, Paparel P, Cognet F, Krause D. Arterial embolization for massive hematuria following transurethral prostatectomy. J Urol. 2002;168:2550–1.

    Article  PubMed  Google Scholar 

  9. Sun F, Sanchez FM, Crisostomo V, et al. Benign prostatic hyperplasia: transcatheter arterial embolization as potential treatment—preliminary study in pigs. Radiology. 2008;246(3):783–9.

    Article  PubMed  Google Scholar 

  10. Bilhim T, Tinto HR, Fernandes L, Martins Pisco J. Radiological anatomy of prostatic arteries. Tech Vasc Interv Radiol. 2012 Dec;15(4):276–85.

    Article  PubMed  Google Scholar 

  11. Mirakhur A, McWilliams J. Protate artery embolization for benign prostatic hyperplasia: current status. Can Assoc of Radiol J. 2017;68:84–9.

    Article  Google Scholar 

  12. • Pisco JM, et al. Medium- and long-term outcome of prostate artery embolization for patients with benign prostatic hyperplasia: results in 630 patients. J Vasc Interv Radiol. 2016;27:1115–22. Highlights long term outcomes of PAE to > 6 years which few other papers have done.

  13. •• Gao YA, Huang Y, Zhang R, Yang YD, Zhang Q, Hou M, et al. Benign prostatic hypertrophy: prostate artery embolization vs. transurethral resection of the prostate, a prospective, randomized controlled trial. Vasc and Interventional Radiology. 2014;270(3):920–8. One of the few prospective, randomized controlled trials comparing PAE to TURP.

  14. •• Carnevale FC, Moreira AM, Antunes AA. The “PErFecTED technique”: proximal embolization first, then embolize distal for benign prostatic hyperplasia. Cardiovasc Interv Radiol. 2013;37:1602–5. The only paper comparing TURP to PAE and Perfected PAE, which is a novel technique that allows for more complete embolization of the prostatic artery.

  15. Moreira AM, de Assis AM, Carnevale FC, Antunes AA, Srougi M, Cerri GG. A review of adverse events related to prostatic artery embolization for treatment of bladder outlet obstruction due to BPH. Cardiovasc Intervent Radiol. 2017 Oct;40(10):1490–500.

    Article  PubMed  Google Scholar 

  16. Carnevale FC, Moreira AM, Antunes AA. The “PErFecTED technique”: proximal embolization first, then embolize distal for benign prostatic hyperplasia. Cardiovasc Interv Radiol. 2013, 37:1602–5.

  17. Bagla S, Smirniotopoulos JB, Orlando JC, van Breda A, Vadlamudi V. Comparative analysis of prostate volume as a predictor of outcome in prostate artery embolization. J Vasc Interv Radiol. 2015;26:1832–8.

    Article  PubMed  Google Scholar 

  18. Bilhim T, Pisco JM, Rio Tinto H, Fernandes L, Campos Pinheiro L, Duarte M, et al. Unilateral vs. bilateral prostatic artery embolization for lower urinary tract symptoms in patients with prostate enlargement. Cardiovasc Intervent Radiol. 2013;36:403–11.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, New York-Presbyterian Hospital, 525 East 68th Street, Starr 900, New York, NY, 10065, USA

    Jonathan Fainberg, Bilal Chughtai, Richard Lee, Alexis Te & Timothy McClure

Authors
  1. Jonathan Fainberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bilal Chughtai
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Richard Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alexis Te
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Timothy McClure
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jonathan Fainberg.

Ethics declarations

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on BPH-Related Voiding Dysfunction

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fainberg, J., Chughtai, B., Lee, R. et al. Prostate Artery Embolization: Current Status 2018. Curr Bladder Dysfunct Rep 13, 21–24 (2018). https://doi.org/10.1007/s11884-018-0463-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11884-018-0463-6

Keywords

Search

Navigation